Presentation TCT 2016 Pulmonary Artery Denervation for Chronic Pulmonary Hypertension I: Experimental Insights Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Alex M. K. Rothman November 01, 2016
Presentation TCT 2016 Atrial Septostomy for Chronic Pulmonary Hypertension Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Gagan D Singh November 01, 2016
Presentation TCT 2016 Surgical Therapy for Chronic Pulmonary Thromboembolic Disease: Does it Work? Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Matthew D. Bacchetta November 01, 2016
Presentation TCT 2016 Impella RVAD-Assisted Acute Pulmonary Embolism Therapy: Rationale and Case Presentation Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, William W. O'Neill November 01, 2016
Presentation TCT 2016 Catheter-directed Interventions For Acute Pulmonary Emboli: Pigtails, Ekos, Angiojet, and Angiovac- Description, Data, and Cases Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Lindsay S. Machan November 01, 2016
Presentation TCT 2016 Acute Pulmonary Thromboembolism: Outcomes of Medical Therapy, Including Lytics Presenter: Ori Ben-Yehuda, Ehtisham Mahmud, Christopher F Barnett November 01, 2016
Presentation TCT 2016 Acute and Chronic Pulmonary Hypertension: Etiology, Pathophysiology, Diagnosis, and Classification Presenter: Ori Ben-Yehuda, Ehtisham Mahmud November 01, 2016
News Daily News Pfizer Discontinues Investigational PCSK9 Inhibitor Bococizumab Michael O'Riordan November 01, 2016
Presentation TCT 2016 Case Presentation: Diabetes, Comorbidities, and Multivessel Disease Presenter: John A. Bittl, David J. Maron, Kishore J. Harjai November 01, 2016
Presentation TCT 2016 PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor November 01, 2016
Presentation TCT 2016 Optimizing Fluid Administration for Contrast Nephropathy Prevention Presenter: Somjot S. Brar, Richard Solomon November 01, 2016
Presentation TCT 2016 Hot Topic #3: Anti-ischemic Therapy: Beta Blockers, ACE Inhibitors, and Ranolazine - Are They Effective? Presenter: Bernard J. Gersh, Felix Mahfoud, Ori Ben-Yehuda November 01, 2016
Presentation TCT 2016 Staying in Medicine: Potential Options Presenter: David O. Williams, William W. O'Neill November 01, 2016
Presentation TCT 2016 COLOR: A Prospective, Multicenter Registry Evaluating the Relationship Between Lipid-Rich Plaque and Two-Year Outcomes After Stent Implantation in Patients With Coronary Artery Disease Presenter: Howard C. Herrmann, Robert J. de Winter, Giora Weisz November 01, 2016
Presentation TCT 2016 When to Stop Being an Interventionalist: Age Alone? Presenter: David O. Williams, Augusto D. Pichard November 01, 2016
Presentation TCT 2016 Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein November 01, 2016
Presentation TCT 2016 I Used to Be an Interventional Cardiologist: Psychological Impact Presenter: David O. Williams, George W. Vetrovec November 01, 2016
Presentation TCT 2016 Overview and Scope of the Problem Presenter: David O. Williams November 01, 2016
Presentation TCT 2016 Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control Presenter: Bernard J. Gersh, Felix Mahfoud November 01, 2016
Presentation TCT 2016 Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator Presenter: Emerson C. Perin, Mark W.I. Webster November 01, 2016